FDA Slow and Secretive in Flawed Drug Research

Double Dose: In Second Case of Flawed Drug Research, FDA Response Was Slow and Secretive by Rob Garver and Charles Seife, Special to ProPublica This week, we reported that the Food and Drug Administration left medicines on the market for years after discovering they were approved based on fraudulent studies by Cetero Research, which did […]